Skip to main content

Table 1 Main characteristics of included studies

From: Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis

Author, Year (Ref)

Country

Centre(s)

Study period

N

Age (years)

Mean/SD(range)

or *Median/IQR

Female (%)

Ventilatory support

ITU admission

Mortality (%)

NIV

MV

Alharty et al., 2020 (1)

SaudiArabia

Single

20/03/20–31/05/20

352

50.6/13.3

45/352 (12.8%)

0/352 (0%)

352/352 (100%)

352/352 (100%)

113/352 (32.1%)

Allou et al., 2021 (2)

France

Single

01/03/20–30/04/20

36

66/56–77*

11/36 (30.5%)

3/36 (8.3%)

2/36(5.6%)

10/36 (27.8%)

0/36 (0%)

Amit et al., 2020 (3)

Israel

Multi

05/03/20–27/04/20

156

72/60–82*

48/156 (30.8%)

39/156 (25%)

93/156(59.7%)

156/156 (100%)

87/156 (55.8%)

Asmarawati et al., 2021 (4)

Indonesia

Single

14/03/20–30/09/20

218

52.4/14.4

98/218 (44.9%)

NR

23/218 (10.5%)

52/218 (23.8%)

21/218 (9.6%)

Ayding Bahat et al., 2020 (5)

Turkey

Single

11/03/20–24/04/20

25

60.5/15

15/25 (60%)

NR

NR

8/25(32%)

5/25(20%)

Balena et al., 2020 (6)

Italy

Single

01/03/20–15/06/20

148

80/72–86*

83/148 (66%)

31/148 (21%)

4/148 (4%)

NR

34/128 (23%)

Baraboutis et al., 2020 (7)

Greece

Single

16/03/20–12/04/20

49

63/20–95*

19/49 (38.8%)

NR

8/49 (16.3%)

NR

6/49 (12.2%)

Bardi et al., 2021 (8)

Spain

Single

01/03/20–01/06/20

140

61/57–67*

32/140 (23%)

NR

134/140 (96%)

140/140 (100%)

51/140 (36%)

Barrasa et al., 2020 (9)

Spain

Single

04/03/20–31/03/20

48

67/53–74*

21/48 (43.8%)

0/48 (0%)

45/48 (94%)

48/48(100%)

16/48 (36%)

Barry et al., 2020 (10)

Saudi

Single

22/03/20–31/05/20

99

44.0/(19–87)

33/99 (33.3%)

9/99 (9.1%)

13/99 (13.1%)

22/99(22.2%)

12/99 (12%)

Basakaran et al., 2021 (11)

UK

Multi

21/02/20–01/05/20

254

59/49–69*

90/254 (35.4%)

NR

151/254 (59.5%)

254/254 (100%)

2/254 (0.8%)

Bhatt et al., 2021 (12)

USA

Multi

01/03/20–07/05/20

375

63.2/16.2

146/375 (38.9%)

7/375 (1.8%)

17/375 (4.5%)

175/375 (46.7%)

149/375 (39.7%)

Buckner et al., 2020 (13)

USA

Multi

02/03/20–26/03/20

105

69/23–97*

52/105 (49.5%)

1/105 (1.0%)

17/105 (16.2%)

51/105 (48.6%)

35/105(33.3%)

Chen et al., 2020 (14)

China

Single

01/01/20–10/02/20

203

54/(20–91)

95/203 (46.8%)

NR

39/203 (19.2%)

39/203 (19.2%)

26/203 (12.8%)

Chen et al., 2021 (15)

China

Single

11/01/20–31/03/20

408

48/34–60*

212/408 (51.9%)

NR

NR

NR

3/408 (0.7%)

Cheng et al., 2020 (16)

China

Single

08/01/20–08/05/20

147

36/24–54*

62/147 (42.1%)

NR

NR

3/147 (2%)

0/147 (0%)

Chengy et al., 2020 (17)

China

Single

01/01/20–18/03/20

62

61/49.3–67.5*

44/62 (70.9%)

NR

NR

NR

0/62 (0%)

Chong et al., 2021 (18)

USA

Single

8/03/20–22/06/20

244

63/51–75*

96/244 (40.6%)

18/244 (7.4%)

71/244 (29.1%)

118/244 (48.4%)

NR

Choubey et al., 2021 (19)

UK

Single

01/03/20–31/05/20

209

NR

NR

NR

NR

NR

NR

Contou et al., 2020 (20)

France

Single

01/03/20–30/02/20

92

NR/(55–70)

19/92 (20.6%)

NR

83/92 (90%)

92/92 (100%)

45/92 (49%)

D’Onofrio et al., 2020 (21)

Belgium

Single

12/03/20–12/04/20

110

73/60–82*

62/110 (56.4%)

NE

NE

29/110(26.4%)

34/110 (30.9%)

Desai et al., 2020 (22)

Italy

Single

01/04/20–30/09/20

536

62.9/12.8

5268/536 (50%)

NR

NR

NR

116/536 (21.6%)

Dolci et al., 2020 (23)

Italy

Single

01/02/20–31/03/20

83

61/(49–67)

11/83 (13.3%)

NR

NR

NR

44/83 (53.0%)

Ekadashi et al., 2021 (24)

India

Single

23/03/20–23/08/20

158

NR

NR

NR

NR

NR

NR

Elabbadi et al., 2021 (25)

France

Single

01/02/20–31/05/20

101

61/53–69*

22/101 (10.8%)

NR

83/101(82.2%)

101/101 (100%)

21/101 (20.8%)

Falcone et al., 2021 (26)

Italy

Single

04/03/20–30/04/20

315

NR

105/315 (33.3%)

68/315 (21.6%)

55/315 (17.5%)

85/315 (26.9%)

70/315 (22.2%)

Fan et al., 2021 (27)

China

Single

01/01/20–31/01/20

55

46.46/14.41

25/55 (45.5%)

NR

NR

NR

0/55 (0%)

Garcia-Vidal et al., 2021 (28)

Spain

Single

01/02/20–30/04/20

989

62/48–74*

437/989 (44.2%)

NR

NR

146/989 (14.8%)

99/989 (10.0%)

Gayam et al., 2020 (29)

USA

Single

01/03/20–30/04/20

350

NR

NR

NR

NR

NR

NR

Goncalves et al., 2021 (30)

USA

Single

01/03/20–20/04/20

242

66/14.75

119/242 (49.2%)

NR

NR

NR

52/242 (22.7%)

Guan et al., 2020 (31)

China

Single

NR

61

56.8/15.1

NR

NR

NR

NR

1/61 (1.6%)

He et al., 2020 (32)

China

Single

01/02/20–28/02/20

192

45/NR

93/192(48.4%)

NR

NR

NR

5/192 (2.6%)

He et al., 2021 (33)

China

Multi

01/01/20–28/02/20

905

47/35–57*

463/905 (51.2%)

NR

NR

NR

57/905 (6.2%)

Huang et al., 2020(34)

China

Single

16/12/19–02/01/20

41

49.0/41.0–58.0*

11/41 (26.8%)

10/41 (24%)

2/41(5%)

NR

6/41(14.6%)

Huang et al., 2020 (34)

China

Single

16/12/19–02/01/20

13

49/41–61*

2/13 (15%)

8/13 (62%)

2/13 (15%)

13/13 (100%)

5/13(38%)

Huang et al., 2021 (35)

USA

Single

01/03/20–31/05/20

41

66.6/19.1

21/41(51.2%)

26/41(63.4%)

15/41(37%)

15/41(36.6%)

15/41(36.6%)

Hughes et al., 2020 (36)

UK

Multi

20/02/20–20/04/20

836

69/55–81*

317/836 (37.9%)

NR

NR

NR

NR

Humières et al., 2021(37)

France

Multi

29/01/20–31/05/20

197

59/(50–68)

48/197 (24.8%)

NR

129/197(67%)

197/197 (100%)

71/197 (26.0%)

Karaba et al., 2021 (38)

USA

Multi

01/03/20–31/05/20

1016

62/48–74*

473/1016(46.5%)

NR

NR

NR

NR

Karami et al., 2021 (39)

Netherlands

Multi

01/03/20–31/05/20

925

70/59–77*

334/925 (36.1%)

NR

NR

NR

214/925 (23.1%)

Kimming et al., 2020(40)

USA

Single

01/03/20–27/04/20

111

NR

49/111 (44.1%)

NR

NR

NR

30/111 (27%)

Kolenda et al., 2020 (41)

France

Multi

01/03/20–15/04/20

99

NR

NR

NR

NR

NR

NR

Lardaro et al., 2021 (42)

USA

Multi

01/03/20–30/04/20

542

64.8/16.5

273/542 (50.4%)

NR

162/542 (29.9%)

86/542 (15.9%)

78/542 (14.4%)

Li et al., 2020 (43)

China

Single

20/01/20–14/02/20

225

50.0/14.0

105/225 (46.7%)

NR

NR

NR

2/225 (0.9%)

Li et al., 2020 (44)

China

Single

27/01/20–17/03/20

1495

NR

NR

NR

NR

NR

NR

Liu et al., 2020 (45)

China

Single

18/01/20–12/03/20

140

65.5/54.3–73.0*

91/140 (65.0%)

NR

NR

NR

NR

Liu et al., 2021 (46)

China

Single

01/01/20–28/02/20

53

38/28–47*

27/53 (50.9%)

32/53 (63.4%)

1/53(1.9%)

1/53 (1.9%)

0/53 (0%)

Liu et al., 2021 (47)

China

Single

26/01/20–18/03/20

1123

61/50–69*

563/1123 (50.1%)

NR

NR

NR

111/1123 (9.9%)

Mady et al., 2020 (48)

Saudi Arabia

Single

12/08/20–12/09/20

61

51/42.5–58.8*

7/61 (11.5%)

32/61 (52.5%)

29/61 (47.5%)

61/61 (100%)

19/61 (31.1%)

Mahmoudi et al., 2020 (49)

Iran

Single

17/02/20–20/10/20

340

NR

NR

NR

NR

NR

NR

Mason et al., 2021 (50)

UK

Multi

01/03/20–31/05/20

800

NR/(18–100)

310/800 (38.7%)

NR

NR

NR

NR

M. Movahed et al., 2021 (51)

Iran

Single

22/02/20–19/04/20

854

55.6/17.63

382/854 (44.7%)

NR

NR

183/854(21/4%)

119/854 (13.9%)

Nassir et al., 2021 (52)

Pakistan

Single

01/02/20–30/06/20

100

58/49–57*

11/100 (11%)

NR

35/100 (35%)

79/100 (79%)

30/100 (30%)

Nebreda et al., 2020 (53)

Spain

Single

08/03/20–31/05/20

712

NR

NR

NR

NR

NR

NR

Pulia et al., 2021 (54)

USA

Multi

15/03/20–18/05/20

73

NR

38/73 (52.1%)

NR

8/73 (10.9%)

NR

NR

Quartuccio et al., 2020(55)

Italy

Single

01/02/20–30/04/20

69

56.2/14.2

25/69 (36.2%)

0/69 (0%)

0/69 (0%)

0/69 (0%)

0/69 (0%)

Richardson et al., 2020 (56)

USAe

Multi

01/03/20–04/04/20

5700

63.0/52.0–75.0

2263/5700 (39.7%)

NR

320/5700 (5.6%)

373/5700 (6.5%)

553/5700 (9.7%)

Rippa et al., 2021 (57)

Italy

Single

25/02/20– 6/04/20

731

64/(55–76)

235/731 (32.1%)

NR

NR

45/731(6.1%)

NR

Rothe et al. 2020 (58)

Germany

Single

01/02/20–30/04/20

140

63.5/(17–99)

50/140 (35.7%)

NR

41/14 0(29.3%)

56/140 (40%)

18/140 (12.8%)

Seaton et al., 2020 (59)

Scotland

Multi

20/04/20–30/04/20

531

72/61–82*

257/531 (48.4%)

NR

NR

110/531 (20.7%)

NR

Shah et al., 2020 (60)

USA

Single

03/02/20–31/03/20

33

63/50–75*

12/33 (36.4%)

0/33(0%)

6/11 (55%)

11/26 (42%)

1/26 (4%)

Shao et al., 2020 (61)

China

Multi

23/01/20–23/03/20

126

NR/(19–91)

58/126 (46.0%)

NR

NR

NR

1/126 (0.1%)

Sharifipour et al., 2020 (62)

Iran

Multi

NR

19

67/4.6

8/19 (42.1%)

NR

NR

19/19(100%)

18/19(94.7%)

Silva et al., 2021 (63)

Brazil

Single

01/05/20–30/11/20

212

NR

86/212 (40.5%)

NR

NR

212/212(100%)

107/212(52.9%)

Singh et al., 2021 (64)

USA

Single

16/03/20–01/08/20

4259

45.2/20–43*

2513/4259 (55.5%)

NR

NR

NR

NR

Soogard et al., 2021 (65)

Switzerland

Single

25/02/20–31/05/20

162

64.4/50.4–74.2*

63/162(38.9%)

NR

34/162(20.9%)

41/162(25.3%)

17/162(10.5%)

Staub et al., 2021 (66)

USA

Single

01/03/20–15/05/20

131

56/17.4

53/131(39.7%)

NR

NR

NR

13/131 (9.9%)

Stevens et al., 2021 (67)

USA

Single

01/03/20–28/04/20

346

45/18

176/346 (51%)

NR

NR

0/346 (0%)

0/346 (0%)

Tang et al., 2021 (68)

China

Single

28/01/20–15/03/20

78

47.7/17.2

37/78(47.4%)

NR

NR

8/78 (10.3%)

NR

Thelen et al., 2021 (69)

Netherlands

Multi

28/02/20–02/06/20

678

70/58–78*

235/678 (34.7%)

NR

NR

6/678 (0.9%)

191/678 (28.3%)

Townsend et al., 2020 (70)

Ireland

Multi

01/03/20–31/04/20

117

NR

43/117 (36.8%)

NR

NR

34/117 (29.1%)

17/117 (14.5%)

Vanhomwegen et al., 2021 (71)

Belgium

Single

03/03/20–02/05/20

66

61/49–71*

25/66 (38%)

NR

NR

66/66 (100%)

20/66 (30.3%)

Vaughn et al., 2021 (72)

USA

Multi

01/03/20–01/06/20

1705

64.7/53.0–76.7*

820/1705 (48.1%)

13/1705 (0.8%)

116 /1705 (6.8%)

NR

325/1705 (19.1%)

Wan et al., 2020 (73)

China

Single

23/01/20–08/02/20

135

47.0/36.0–55.0*

63/135 (46/7%)

34/135 (19.4%)

1/135 (0.7%)

40/135 (29.6%)

1/135 (0.7%)

Wan et al., 2020 (73)

China

Single

23/01/20–08/02/20

40

56.0/52.0–73.0*

19/40 (47.5%)

27/40 (67.5%)

1/40 (2.5%)

40/40

1/40 (2.5%)

Wang et al., 2020 (74)

China

Single

29/01/20–10/02/20

28

68.6/9.0 (53–82)

7/28 (25%)

11/28 (39.3%)

7/28 (25%)

14/28 (50%)

12/28 (42.9%)

Wang et al., 2020 (74)

China

Single

29/01/20–10/02/20

14

71.4/7.9

4/14(71.4%)

11/14 (79.6%)

7/14 (50%)

14/14 (100%)

12/14 (85.7%)

Wang et al., 2020 (75)

China

Single

01/01/20–06/02/20

339

69.0/65.0–76.0*

173/339(51.0%)

NR

NR

65/339 (19.2%)

65/339 (19.2%)

Wang et al., 2021 (76)

UK

Multi

01/03/20–30/04/20

1396

67.4/16.2

NR

NR

NR

226/1396 (16.2%)

420/1396 (30.1%)

Xu et al., 2021 (77)

China

Single

Up to 12/03/20

62

56.5/45.3–74.8*

27/62 (44%)

24/62 (45%)

15/62 (24%)

62/62 (100%)

7/62 (11.3%)

Yang et al., 2020 (78)

China

Single

05/01/20–22/02/20

251

NR

128/251 (51.0%)

NR

NR

NR

21/251 (8.4%)

Zhang et al., 2020 (79)

China

Single

02/01/20–10/02/20

221

55.0/39.0–66.5*

113/221 (51.1%)

26/221 (12.2%)

16/221 (7.2%)

NR

12/221 (5.4%)

Zhang et al., 2020 (80)

China

Single

16/01/20–03/02/20

140

57.0/25.0–87.0*

69/140 (49.3%)

NR

NR

NR

NR

Zhang et al., 2020 (81)

China

Single

22/01/20–30/04/20

38

64.7/13.7

6/38 (15.8%)

NR

NR

NR

NR

Zhang et al., 2020 (82)

China

Single

10/12/19–20/02/20

134

60.8/12.9

47/134 (35.1%)

91/134 (67.9%)

79/134 (58.9%)

134/134 (100%)

101/134 (75.4%)

Zhang et al., 2021 (83)

China

Single

01/01/20–28/02/20

91

74.9/68–82*

52/91 (57.1%)

3/91 (3.3%)

11/91 (12.1%)

NR

5/91 (55.6%)

Zhang et al., 2020 (84)

China

Single

01/01/20–31/03/20

365

46.8/15.5

189/365(51.8%)

NR

NR

NR

2/365(0.5%)

Zhao et al., 2020 (85)

China

Single

01/01/20–28/02/20

1000

61/46–70*

534/1000 (53.4%)

147/1000 (14.7%)

43/1000 (4.3%)

63/1000 (6.3%)

119/1000 (11.9%)

  1. N: number. NR: not reported. IQR: interquartile range. SD: standard deviation, SOCa: standard of care
  2. NIV: Non-invasive ventilation, MV: mechanical ventilation, ITU: intensive treatment unit
  3. Full list of references are in Additional file 1: Material S4